Seasonal influenza vaccine could reduce cardiovascular events in type 2 diabetes patients

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2016年 / 12卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2216 / 2216
页数：1
相关论文
共 50 条
  • [31] Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes
    A. Moura Neto
    M. C. R. Parisi
    M. A. Tambascia
    E. J. Pavin
    S. M. Alegre
    D. E. Zantut-Wittmann
    Endocrine, 2014, 45 : 84 - 91
  • [32] Pulse pressure predicts the risk of cardiovascular events in patients with type 2 diabetes
    Cockcroft, JR
    Wilkinson, IB
    McKewan, P
    Evans, LM
    Davies, JS
    Peters, JR
    Currie, CJ
    JOURNAL OF HYPERTENSION, 2002, 20 : S176 - S176
  • [33] Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes
    Malik, Mariam Elmegaard
    Andersson, Charlotte
    Blanche, Paul
    D'Souza, Maria
    Madelaire, Christian
    Zareini, Bochra
    Lamberts, Morten
    Kristensen, Soren Lund
    Sattar, Naveed
    McMurray, John
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar
    Schou, Morten
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (02) : 215 - 226
  • [34] Canagliflozin and cardiovascular and renal events in type 2 diabetes
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2018, 130 (02) : 149 - 153
  • [35] An α-glucosidase inhibitor could reduce T-wave alternans in type 2 diabetes patients
    Eguchi, Kazuo
    Komori, Takahiro
    Saito, Toshinobu
    Hoshide, Satoshi
    Kario, Kazuomi
    JOURNAL OF ELECTROCARDIOLOGY, 2018, 51 (01) : 21 - 26
  • [36] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Fernandez-Balsells, M. Merce
    Sojo-Vega, Lidia
    Ricart-Engel, Wifredo
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21): : 2098 - 2098
  • [37] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Neal, Bruce
    Perkovic, Vlado
    Mahaffey, Kenneth W.
    de Zeeuw, Dick
    Fulcher, Greg
    Erondu, Ngozi
    Shaw, Wayne
    Law, Gordon
    Desai, Mehul
    Matthews, David R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07): : 644 - 657
  • [38] Could pravastatin reduce the risk of type a diabetes?
    Chande, M
    LANCET, 2001, 357 (9252): : 287 - 287
  • [39] Cardiovascular events and atherosclerosis in patients with type 2 diabetes and impaired glucose tolerance: What are the medical treatments to prevent cardiovascular events in such patients?
    Ishii, Hideki
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (07) : 1114 - 1121
  • [40] Hypoglycemic Events May Be Associated with an Increased Risk of Acute Cardiovascular Events in Patients with Type 2 Diabetes
    Johnston, Stephen S.
    Conner, Christopher
    Aagren, Mark
    Smith, David M.
    Bouchard, Jonathan
    DIABETES, 2010, 59 : A8 - A8
12345